Form D
View Original Filing
Notice of Exempt Offering of Securities
Item 1. Issuer's Identity
Name of Issuer:
CORONADO BIOSCIENCES INC
Jurisdiction of Incorporation/Organization
DE
Year of Incorporation/Organization
2006
Item 2 Issuer Principal Place of Business and Contact Information
1700 SEVENTH AVENUE
SUITE 2100
SEATTLE, WA 98101
Phone Number:
subscription required
Item 3. Related Persons
Name
RAYMOND J. TESI
Address
subscription required
Relationship(s)
- EXECUTIVE OFFICER
- DIRECTOR
Clarification of Response
Item 3. Related Persons
Name
ELIZABETH MOORE
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
LINDA ROGERS
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
J. JAY LOBELL
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
TIMOTHY M. HOFER
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
STEPHEN PILATZKE
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
JIMMIE HARVEY
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
PEGGY WENTWORTH
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
LINDSAY A. ROSENWALD
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
GLENN L. COOPER
Address
subscription required
Relationship(s)
Clarification of Response
Item 4. Industry Group
PHARMACEUTICALS
Item 5. Issuer Size
Revenue Range (for issuer not specifying "hedge" or "other investment" fund in Item 4 above)
DECLINE TO DISCLOSE
Item 6. Federal Exemptions and Exclusions Claimed
Item 7. Type of Filing
New Notice
Date of First Sale in this Offering:
04/26/2010
Item 8. Duration of Offering
Does the issuer intend this offering to last more than one year?
No
Item 9. Type(s) of Securities Offered
- Equity
- Option, Warrant or Other Right to Acquire Another Security
- Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security
Item 10. Business Combination Transaction
Is this offering being made in connection with a business combination
transaction, such as a merger, acquisition or exchange offer?
No
Clarification of Response
Item 11. Minimum Investment
Minimum Investment accepted from any outside investor
0
Item 12. Sales Compensation
Recipient
PARAMOUNT BIOCAPITAL, INC.
Recipient CRD Number
29795
(Associated) Broker or Dealer)
NONE
(Associated) Broker or Dealer CRD Number
NONE
Address
787 SEVENTH AVENUE, 48TH FLOOR
NEW YORK, NY 10019
States of Solicitation
Item 13. Offering and Sales Amounts
Total Offering Amount
7700002
Total Amount Sold
7000000
Total Remaining to be Sold
700002
Clarification of Response
Item 14. Investors
Securities in the offering have been or may be sold to persons
who do not qualify as accredited investors,
Number of non-accredited investors who already have invested in the offering:
Total number of investors who already have invested in the offering:
25
Item 15. Sales Commissions and Finders' Fees Expenses
Sales Commissions:
700000.0
Finders' Fees
0.0
Clarification of Response
UPON EACH CLOSING, THE ISSUER WILL PAY PARAMOUNT COMMISSIONS EQUAL TO 10% OF THE GROSS PROCEEDS RECEIVED AT SUCH CLOSING. THE COMMISSIONS PAID ABOVE WERE NOT APPLIED TO THE PURCHASE OF SECURITIES BY ONE INVESTOR.
Item 16. Use of Proceeds
Provide the amount of the gross proceeds of the offering
that has been or is proposed to be used for payments to any of the persons required
to be named as executive officers,directors or promoters in response to Item 3 above.
0.0 Is an estimate
Clarification of Response
Signature and Submission
Issuer Name
CORONADO BIOSCIENCES INC
Issuer Signature
TIMOTHY HOFER
Signer Name
TIMOTHY HOFER
Signer Title
SECRETARY
Signature Date
05/05/2010
